Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Episode 078: Management of relapsed diffuse large B-cell lymphoma (DLBCL) - Part 2

Episode 078: Management of relapsed diffuse large B-cell lymphoma (DLBCL) - Part 2

FromThe Fellow on Call: The Heme/Onc Podcast


Episode 078: Management of relapsed diffuse large B-cell lymphoma (DLBCL) - Part 2

FromThe Fellow on Call: The Heme/Onc Podcast

ratings:
Length:
20 minutes
Released:
Oct 25, 2023
Format:
Podcast episode

Description

In this FINAL episode of our DLBCL series, we build on our conversation from last week, focusing on the management of relapsed DLBCL. If you have not done so already, we recommend you check out Episode 077! Content: - Treatment with selective antibodies against CD19- How to approach relapsed disease after CAR-T - Use of BiTE therapy - Role of allo? ** Want to review the show notes for this episode and others? Check out our website: https://www.thefellowoncall.com/our-episodesLove what you hear? Tell a friend and leave a review on our podcast streaming platforms!Twitter: @TheFellowOnCallInstagram: @TheFellowOnCallListen in on: Apple Podcast, Spotify, and Google Podcast
Released:
Oct 25, 2023
Format:
Podcast episode

Titles in the series (100)

We quickly realized we knew very little about hematology and oncology when we started fellowship. Our goal is to bring you the fundamentals, core concepts and important management approaches in our field, driven by the latest evidence and expert opinion. In each episode, we will provide bite-sized, simplified approaches to common questions in a way that is perfect for anyone interested in hematology and oncology, from students and trainees to advanced practice providers and practicing physicians.